Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrien Vandecasteele

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelinesPiet Ost, Gert De Meerleer, Tom Vercauteren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapyCharles Van Praet, Piet Ost, Nicolaas Lumen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancerValérie Fonteyne, Werner De Gersem, Wilfried De Neve, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?Patrick Berkovic, Leen Paelinck, Yolande Lievens, et al.
Frontiers in Oncology|July 29, 2022
Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical CancerTeodora Oltean, Lien Lippens, Kelly Lemeire, et al.
World Journal of Surgical Oncology|March 7, 2023
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohortAxel Van Damme, Julie Rombaut, Amin Makar, et al.
Technology in Cancer Research & Treatment|April 5, 2023
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER StudyValérie Fonteyne, Willeke Danckaert, Piet Ost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomyGert De Meerleer, Valérie Fonteyne, Sabine Meersschout, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2012
Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched studyKatrien Vandecasteele, Louke Delrue, Bieke Lambert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 17, 2009
Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementationKatrien Vandecasteele, Wilfried De Neve, Werner De Gersem, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelinesPiet Ost, Gert De Meerleer, Tom Vercauteren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapyCharles Van Praet, Piet Ost, Nicolaas Lumen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancerValérie Fonteyne, Werner De Gersem, Wilfried De Neve, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?Patrick Berkovic, Leen Paelinck, Yolande Lievens, et al.
Frontiers in Oncology|July 29, 2022
Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical CancerTeodora Oltean, Lien Lippens, Kelly Lemeire, et al.
World Journal of Surgical Oncology|March 7, 2023
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohortAxel Van Damme, Julie Rombaut, Amin Makar, et al.
Technology in Cancer Research & Treatment|April 5, 2023
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER StudyValérie Fonteyne, Willeke Danckaert, Piet Ost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomyGert De Meerleer, Valérie Fonteyne, Sabine Meersschout, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2012
Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched studyKatrien Vandecasteele, Louke Delrue, Bieke Lambert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 17, 2009
Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementationKatrien Vandecasteele, Wilfried De Neve, Werner De Gersem, et al.
Pageof 6